Terlalu Panas, Kompresor Pabrik di Jombang Meledak hingga Picu Kebakaran - Viva.co.
| OMED Stock | 184.00 1.00 0.54% |
About 61% of Jayamas Medica's investor base is looking to short. The analysis of current outlook of investing in Jayamas Medica Industri suggests that many traders are alarmed regarding Jayamas Medica's prospects. Jayamas Medica's investing sentiment shows overall attitude of investors towards Jayamas Medica Industri.
Jayamas |
Terlalu Panas, Kompresor Pabrik di Jombang Meledak hingga Picu Kebakaran Viva.co.
Read at news.google.com
 |
Jayamas Medica Fundamental Analysis
We analyze Jayamas Medica's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jayamas Medica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jayamas Medica based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Jayamas Medica is rated below average in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Jayamas Medica Industri Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Jayamas Medica stock to make a market-neutral strategy. Peer analysis of Jayamas Medica could also be used in its relative valuation, which is a method of valuing Jayamas Medica by comparing valuation metrics with similar companies.
Peers
Jayamas Medica Related Equities
| BIPP | Bhuwanatala Indah | 3.45 | ||||
| MEDS | PT Hetzer | 0.00 | ||||
| MASA | Multistrada Arah | 0.00 | ||||
| OMED | Jayamas Medica | 0.54 | ||||
| MARK | Mark Dynamics | 1.86 | ||||
| MBAP | Mitrabara Adiperdana | 1.87 | ||||
| WOOD | Integra Indocabinet | 1.90 | ||||
| IATA | PT MNC | 2.04 | ||||
| ADRO | Adaro Energy | 2.83 | ||||
| PSAB | J Resources | 5.00 |
Other Information on Investing in Jayamas Stock
Jayamas Medica financial ratios help investors to determine whether Jayamas Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jayamas with respect to the benefits of owning Jayamas Medica security.